Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients.
Palma M, Hansson L, Mulder TA, Adamson L, Näsman-Glaser B, Eriksson I, Heimersson K, Ryblom H, Mozaffari F, Svensson A, Gentilcore G, Österborg A, Mellstedt H.
Palma M, et al. Among authors: mozaffari f.
Eur J Haematol. 2018 Jul;101(1):68-77. doi: 10.1111/ejh.13065. Epub 2018 May 22.
Eur J Haematol. 2018.
PMID: 29569742
Clinical Trial.